JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
QUICK SEARCH:   [advanced]


     

Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on June 29, 2005; DOI: 10.1124/jpet.105.089359

This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.105.089359v1
315/1/240    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ocheltree, S.
Right arrow Articles by Smith, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ocheltree, S.
Right arrow Articles by Smith, D.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH


Received for publication May 12, 2005.
Revised June 23, 2005.
Accepted for publication June 23, 2005.

Role and Relevance of PEPT2 in the Kidney and Choroid Plexus: In Vivo Studies with Glycylsarcosine in Wild-Type and PEPT2 Knockout Mice

Scott Ocheltree 1, Hong Shen 1, Yongjun Hu 1, Richard Keep 1, David Smith 1*

1 University of Michigan

* Address correspondence to: E-mail: smithb{at}umich.edu

Abstract

The strategic localization of PEPT2, a proton-coupled oligopeptide transporter, to the apical membrane of epithelial cells in the kidney and choroid plexus suggests that it plays an important role in the disposition of peptides/mimetics in the body. Therefore, the in vivo significance of PEPT2 was investigated in wild-type and PEPT2 null mice following an intravenous bolus dose (0.05 µmol/g body weight) of [14C]glycylsarcosine (GlySar). In PEPT2 null mice, the clearance (total and renal) of GlySar was markedly increased (2-fold), resulting in concomitantly lower systemic concentrations. In addition, renal reabsorption was almost abolished and GlySar was eliminated by glomerular filtration. Out of the 46% of GlySar reabsorbed in wild-type mice, PEPT2 accounted for 86% and PEPT1 accounted for 14% of reabsorbed substrate. Analysis of GlySar uptake in kidney sections revealed that PEPT2 was primarily localized in the outer medullary region. Wild-type mice also had greater choroid plexus concentrations of GlySar and a 5-fold greater choroid plexus/CSF ratio as compared to null mice at 60 min. Null mice exhibited a greater CSF/blood ratio at 60 min (0.9 vs. 0.2) and AUCCSF/AUCblood ratio over 60 min (0.45 vs. 0.12), indicating that PEPT2 significantly reduces the exposure of GlySar in CSF. Our in vivo results demonstrate that PEPT2 is the predominant peptide transporter in kidney and that it acts as an efflux transporter in choroid plexus. Thus, PEPT2 may have profound effects on the sensitivity and/or toxicity of peptides and peptide-like drugs.


Key words: Choroid Plexus, Disposition, GlySar, Kidney, Knockout Mice, PEPT2


This article has been cited by other articles:


Home page
 Toxicol SciHome page
C. D. Klaassen and H. Lu
Xenobiotic Transporters: Ascribing Function from Gene Knockout and Mutation Studies
Toxicol. Sci., February 1, 2008; 101(2): 186 - 196.
[Abstract] [Full Text] [PDF]

Home page
 Drug Metab. Dispos.Home page
H. Shen, S. M. Ocheltree, Y. Hu, R. F. Keep, and D. E. Smith
Impact of Genetic Knockout of PEPT2 on Cefadroxil Pharmacokinetics, Renal Tubular Reabsorption, and Brain Penetration in Mice
Drug Metab. Dispos., July 1, 2007; 35(7): 1209 - 1216.
[Abstract] [Full Text] [PDF]

Home page
 Physiol. GenomicsHome page
I. M. Frey, I. Rubio-Aliaga, A. Siewert, D. Sailer, A. Drobyshev, J. Beckers, M. H. de Angelis, J. Aubert, A. B. Hen, O. Fiehn, et al.
Profiling at mRNA, protein, and metabolite levels reveals alterations in renal amino acid handling and glutathione metabolism in kidney tissue of Pept2-/- mice
Physiol Genomics, February 12, 2007; 28(3): 301 - 310.
[Abstract] [Full Text] [PDF]


Home Help [Feedback] [For Subscribers] [Archive] [Search] --
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 2005 by the American Society for Pharmacology and Experimental Therapeutics.